S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NYSE:CNMD

CONMED (CNMD) Stock Price, News & Analysis

$80.03
-0.11 (-0.14%)
(As of 03/28/2024 ET)
Today's Range
$79.54
$81.22
50-Day Range
$75.32
$103.60
52-Week Range
$74.67
$138.47
Volume
407,825 shs
Average Volume
579,391 shs
Market Capitalization
$2.46 billion
P/E Ratio
39.23
Dividend Yield
1.00%
Price Target
$120.43

CONMED MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
50.4% Upside
$120.43 Price Target
Short Interest
Bearish
12.77% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.00mentions of CONMED in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
30.65%
From $4.34 to $5.67 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.96 out of 5 stars

Medical Sector

21st out of 938 stocks

Electromedical Equipment Industry

1st out of 20 stocks

CNMD stock logo

About CONMED Stock (NYSE:CNMD)

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CNMD Stock Price History

CNMD Stock News Headlines

3 Retirement Stocks to Buy at a 52-Week Low in March
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
CNMD Apr 2024 120.000 call
CNMD Apr 2024 90.000 put
CONMED Corporation declares $0.20 dividend
A lot of people are making this costly mistake
You may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
CONMED Corporation Announces Quarterly Cash Dividend
CNMD Mar 2024 80.000 call
CNMD Mar 2024 80.000 put
CNMD Mar 2024 105.000 call
CNMD Mar 2024 90.000 put
Cracking The Code: Understanding Analyst Reviews For Conmed
Piper Sandler Reaffirms Their Buy Rating on Conmed (CNMD)
These Analysts Revise Their Forecasts On CONMED After Q4 Results
Recap: Conmed Q4 Earnings
See More Headlines
Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 1/5 Dividend
12/15/2023
Dividend Payable
1/05/2024
Last Earnings
1/31/2024
Ex-Dividend for 4/5 Dividend
3/14/2024
Today
3/28/2024
Dividend Payable
4/05/2024
Next Earnings (Estimated)
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Employees
4,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$120.43
High Stock Price Target
$141.00
Low Stock Price Target
$98.00
Potential Upside/Downside
+50.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$64.46 million
Pretax Margin
6.49%

Debt

Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$6.29 per share
Book Value
$27.13 per share

Miscellaneous

Free Float
28,442,000
Market Cap
$2.46 billion
Optionable
Optionable
Beta
1.33
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

CNMD Stock Analysis - Frequently Asked Questions

Should I buy or sell CONMED stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CNMD shares.
View CNMD analyst ratings
or view top-rated stocks.

What is CONMED's stock price target for 2024?

7 analysts have issued 1-year price targets for CONMED's shares. Their CNMD share price targets range from $98.00 to $141.00. On average, they expect the company's share price to reach $120.43 in the next year. This suggests a possible upside of 50.4% from the stock's current price.
View analysts price targets for CNMD
or view top-rated stocks among Wall Street analysts.

How have CNMD shares performed in 2024?

CONMED's stock was trading at $109.51 on January 1st, 2024. Since then, CNMD shares have decreased by 26.9% and is now trading at $80.08.
View the best growth stocks for 2024 here
.

Are investors shorting CONMED?

CONMED saw a decline in short interest during the month of February. As of February 15th, there was short interest totaling 4,050,000 shares, a decline of 15.6% from the January 31st total of 4,800,000 shares. Based on an average trading volume of 501,400 shares, the short-interest ratio is currently 8.1 days.
View CONMED's Short Interest
.

When is CONMED's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our CNMD earnings forecast
.

How were CONMED's earnings last quarter?

CONMED Co. (NYSE:CNMD) issued its quarterly earnings results on Wednesday, January, 31st. The company reported $1.06 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.11 by $0.05. The company had revenue of $327.05 million for the quarter, compared to the consensus estimate of $332.94 million. CONMED had a net margin of 5.18% and a trailing twelve-month return on equity of 13.69%.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED announced a quarterly dividend on Monday, February 26th. Investors of record on Friday, March 15th will be given a dividend of $0.20 per share on Friday, April 5th. This represents a $0.80 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date is Thursday, March 14th.
Read our dividend analysis for CNMD
.

Is CONMED a good dividend stock?

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 1.04%. The dividend payout ratio is 39.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNMD will have a dividend payout ratio of 14.11% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CNMD.

What guidance has CONMED issued on next quarter's earnings?

CONMED issued an update on its FY 2024 earnings guidance on Wednesday, January, 31st. The company provided earnings per share (EPS) guidance of 4.300-4.400 for the period, compared to the consensus EPS estimate of 4.400. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

Who are CONMED's major shareholders?

CONMED's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.12%), Vanguard Group Inc. (11.11%), Capital Research Global Investors (8.97%), Dimensional Fund Advisors LP (2.32%), Principal Financial Group Inc. (1.95%) and Voya Investment Management LLC (1.60%). Insiders that own company stock include Brian Concannon, Curt R Hartman, Daniel S Jonas, John D Ferrell, Johonna Marie Pelletier, Peter K Shagory, Stanley W Peters III, Todd W Garner and Todd W Garner.
View institutional ownership trends
.

How do I buy shares of CONMED?

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CNMD) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners